Daily8d
Transanal TME Proves Noninferior to Laparoscopic Approach in 3-Year Disease-Free Survival for Rectal Cancer: TaLaR Trial
The 3-year local recurrence rate was 3.6% for transanal TME and 4.4% for laparoscopic TME. The 3-year overall survival was 92 ...
Targeted Oncology11d
Watch and Wait Post-TNT Safe with Similar Outcomes to TME in Rectal Cancer
A "watch and wait" strategy after total neoadjuvant therapy showed similar outcomes and safety to total mesorectal in stage ...
IEEE3d
Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients
Abstract: Short-course preoperative radiotherapy (SCPRT) is an alternative method to chemoirradiation for patients with Stage II and III rectal cancer when ... were treated with SCPRT and surgery ...
Frontiers9d
The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy
Patients received open surgery. Radiotherapy was administered with 3 ... A total of 837 patients with stage II/III rectal cancer who underwent nCRT and TME in our center from June 2008 to July 2017 ...
Too Old to Operate18h
Understanding Patient and Surgeon Perspectives in Rectal Cancer Care
A qualitative study of surgeon-patient communication in the rectal cancer consultations,” published in the November 2024 ...
Medscape2d
Radiation Intensification Enhances Response in Rectal Cancer
Radiation dose intensification improves pathologic complete response rates in locally advanced rectal cancer but also leads ...
Cure Today8h
Breaking Down The Importance of Targeted Therapies in Colorectal Cancer Care
Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.
ascopubs.org16d
WW vs TME in patients with rectal cancer with a complete or near-complete response to TNT: Pooled analysis of CAO/ARO/AIO-12 and OPRA trials.
Tumour-free ctDNA detection as a decision tool to support organ preservation in node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II NEO trial ...